Entera Bio Ltd (ENTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $525.90M
Last updated: Nov 17, 2026 at 4:26 PM ET
Entera Bio Ltd (ENTX) Stock Chart
Entera Bio (ENTX) has a latest price of $3.00 on Nov 17, 2026, 28.6% below its 52-week high of $4.20. Its price rose 10.7% over the past 12 months. The month-end price fell 49.2% since Jun 2018, a compound annual decline of 7.8%.
Price Chart
From Jun 2018 to Oct 2026, its highest month-end close was $6.30 in Jun 2018 and its lowest $0.60 in Dec 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ENTX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ENTX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 3.5%, and over 6 months it rose 136.2%. The month-end price rose 367.2% over the 3 years through Oct 2026, a compound annual rate of 67.2%.
| Period | Change |
|---|---|
| 1 month | +2.0% |
| 3 months | -3.5% |
| 6 months | +136.2% |
| 12 months | +10.7% |
| 12 months, with dividends | +10.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +367.2% | +67.2% |
| 5 years | -24.9% | -5.6% |
| Since Jun 2018 | -49.2% | -7.8% |
Price by Year
Its best calendar year was 2024, when the price rose 253.3%, and its weakest was 2022, when it fell 74.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.20 | +64.9% |
| 2025 | $1.94 | -8.5% |
| 2024 | $2.12 | +253.3% |
| 2023 | $0.60 | -17.8% |
| 2022 | $0.73 | -74.1% |
| 2021 | $2.81 | +160.6% |
| 2020 | $1.08 | -49.5% |
| 2019 | $2.14 | -29.8% |
Trading Range
The price is 3.4% above its 50-day average of $2.90 and 49.8% above its 200-day average of $2.00.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.00 | |
| 52-week high | $4.20 | -28.6% |
| 52-week low | $0.91 | +229.7% |
| 50-day average | $2.90 | +3.4% |
| 200-day average | $2.00 | +49.8% |
Price Risk
Over 3 years, its largest fall from a peak was 68.2%.
| Measure | Value |
|---|---|
| 1-year beta | 0.86 |
| Largest fall, 1 year | -62.7% |
| Largest fall, 3 years | -68.2% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ENTX
What is ENTX's 1-year price change?
Entera Bio's price rose 10.7% over the past 12 months. With dividends included, the 12-month total return was 10.7%.
What is ENTX's 5-year price change?
Entera Bio's month-end price fell 24.9% over the 5 years through Oct 2026, a compound annual decline of 5.6%. These figures leave out dividends.
What is ENTX's 52-week high and low?
Entera Bio's 52-week high is $4.20 and its 52-week low is $0.91. Its latest price of $3.00 on Nov 17, 2026 is 28.6% below the high.
What is ENTX's beta?
Entera Bio's 1-year beta against the S&P 500 is 0.86, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 62.7%.
Is the ENTX chart free?
Yes. Advanced Charting for ENTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ENTX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors